Related Experiment Video

Updated: May 20, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

Octocog alfa (Advate®): a guide to its use in hemophilia A

Gillian M Keating1, Sohita Dhillon

  • 1Adis, Auckland, New Zealand. demail@springer.com

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|July 5, 2012
PubMed

Insights

Octocog alfa (Advate®), a factor VIII concentrate, effectively prevents and treats bleeding in hemophilia A patients. Routine prophylaxis with Advate® is more effective than on-demand therapy for preventing bleeds.

Area of Science:

  • Hematology
  • Pharmacology

Background:

  • Hemophilia A is a genetic bleeding disorder caused by factor VIII deficiency.
  • Effective management strategies are crucial for preventing bleeding episodes and improving patient quality of life.

Purpose of the Study:

  • To evaluate the efficacy and safety of octocog alfa (Advate®) for hemophilia A management.
  • To compare routine prophylaxis with on-demand therapy using Advate®.

Main Methods:

  • Review of evidence on octocog alfa (Advate®) for prophylaxis and on-demand therapy.
  • Assessment of perioperative management in pediatric and adult hemophilia A patients.

Main Results:

  • Octocog alfa (Advate®) is effective for bleeding prevention, treatment, and perioperative management.
  • Routine prophylaxis with Advate® demonstrates superior efficacy in preventing bleeding episodes compared to on-demand therapy.
  • Advate® is generally well-tolerated, with rare serious adverse events including inhibitor development and hypersensitivity.

Conclusions:

  • Octocog alfa (Advate®) is an effective therapeutic option for pediatric and adult patients with hemophilia A.
  • Routine prophylaxis with Advate® offers enhanced protection against bleeding episodes.
  • Further comparative trials are needed to directly compare Advate® with other factor VIII concentrates.

More Related Videos

Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine09:37

Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine

Published on: August 24, 2018

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...